USANA Health Sciences (USNA) Tops Q1 EPS by 2c, Slight Beat on Revenues; Affirms FY19 EPS/Revenue Guidance

Go back to USANA Health Sciences (USNA) Tops Q1 EPS by 2c, Slight Beat on Revenues; Affirms FY19 EPS/Revenue Guidance

USANA Health Sciences Inc. (USNA) PT Raised to $105 at Pivotal Research

May 1, 2019 1:22 PM EDT

Pivotal Research analyst Timothy Ramey raised the price target on USANA Health Sciences Inc. (NYSE: USNA) to $105.00 (from $95.00) while maintaining a Buy rating.

Ramey commented, "USNAs 1Q19 EPS at $1.01 vs. was in line with the pre-release range and our $1.00 estimate. As previously... More